http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114540498-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ece7343edeac322c185b376f9820b3d4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 |
| filingDate | 2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae06380aa1f8141b46117d6d6d46f8a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b02536771c73f4200aa3dcef5ef1421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2042f9827e945247e7add609cee3c513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1e33f30eed50b29af9ae4616bcb57ee |
| publicationDate | 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114540498-A |
| titleOfInvention | A DNA methylation-based classification device for invasive gliomas |
| abstract | The invention relates to the technical field of biomedicine, in particular to a classification device for invasive glioma based on DNA methylation. The device includes a detection module, a classification module and an information display module; by measuring the degree of methylation of CpG islands To predict whether glial cells are cancerous and the degree of canceration, and classify gliomas, real-time quantitative methylation-specific PCR is not only sensitive and accurate, but also can detect DNA in formalin-soaked specimens. Methylation status, so real-time quantitative methylation-specific PCR has the potential to be used for the diagnosis of glioma. Since miRNA can exist stably in serum and is easy to obtain, it has the potential to become a molecular marker for early diagnosis. The content of miR-25 and miR-223 can be used as diagnostic markers for patients with non-small cell lung cancer; after screening specific glioma miRNA markers and extracting DNA from the patient's blood, the expression level of miRNA can be detected by PCR. Glioma can be diagnosed early. |
| priorityDate | 2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.